Gabriel Alves Freiria Oliveira

Mr. Gabriel Alves Freiria Oliveira

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GOGabriel Alves Freiria Oliveira
Gabriel Alves Freiria Oliveira
DODaniel Arcuschin de Oliveira
Daniel Arcuschin de Oliveira
MNMelissa Yoshimi Sakamoto Maeda Nisimoto
Melissa Yoshimi Sakamoto Maeda Nisimoto
RRRafael Rubinho
Rafael Rubinho
HGHeitor Carvalho Gomes
Heitor Carvalho Gomes
Renato SO FilhoRenato SO Filho
Renato SO Filho
Invasive cutaneous melanoma is responsible for about 5% of skin tumors yet is liable for nearly 70% of skin cancer-related deaths. Despite notable advancements over the past decade, including immunotherapies and targeted treatments, more than half of invasive melanoma patients ultimately succumb to the disease due to therapeutic resistance. To overcome this obstacle, strategies such as combining immunotherapies with targeted drugs or adding epigenetic therapies have been investigated. Tumor-infiltrating lymphocytes (TILs) therapy has emerged as a promising option for patients whose disease continues to progress despite standard treatments. This article aims to introduce TIL therapy and review recent outcomes in melanoma prognosis in its application for melanoma management.